The Future of the FDA Accelerated Approval Program on Outcomes for Patients
Nov 5, 2024
Watch our latest webinar to gain comprehensive insights into the future of the FDA Accelerated Approval Program (AAP) and its impact on patients. You will learn how to:
• Quantitative Benefits: Assess new specific evidence that shows how many estimated life years have been gained by cancer patients due to earlier treatment access provided by the AAP
• Policy Evaluation: Evaluate the AAP with a thorough assessment of its actual effects on patient outcomes and how they can be improved
• Patient-Centric Policies: How to develop health policies that prioritize patient outcomes and are based on solid evidence to secure future access to innovative therapies
For more content like this, including panel discussions, articles, in-depth reports & upcoming events, join thousands of pharma leaders who read our monthly Pharma Insights by Reuters Events email newsletter here